Scrip
Clinica
Scrip Regulatory Affairs
Scrip Clinical Research
AnimalPharm
Email ID
Password
Forgotten your password?
Sign me in automatically next time
Advanced Search
Home
Therapy Sector
Generics
Business
Policy & Regulation
Research & Development
International
Pricing & Reimbursement
|
Regulation
|
Healthcare Policy
|
Pharmacovigilance
|
Intellectual Property
|
Policy & Regulation Staging - Pharmacovigilance
About Us
Getting Started
Subscribe
Free Trial
Advertise
Awards
White Papers
Executive Briefing
Classifieds
Recruitment
JOB OF THE WEEK
Promote your vacancy here
SCRIP's ONLINE DIRECTORY
Classified ads
LATEST NEWS
US FDA keeps propoxyphene on the market
08 July 2009
Generics firms urge EC to help boost sales in EU and emergin...
Shionogi snatches Victory portfolio from jaws of past defeat...
More resources needed for EU and US regulatory demands, report reveals
29 June 2009
US FDA orders boxed warnings on toxin spread for Botox and Myobloc
01 May 2009
US panel narrowly favours banning Darvon, Darvocet
03 February 2009
>> More News...
LATEST ANALYSIS
Market Insight - Product safety takes centre stage
27 May 2009
Market Insight: F-D-triple-A steps out to a mixed reception
31 July 2008
>> More Analysis...
LATEST COMMENT
Life under FDAAA: Four months of post-approval studies and REMS
01 August 2008
>> More Comment...
REFINE BY
COMPANY/ORGANISATION
GLAXOSMITHKLINE
PFIZER
NOVARTIS
SANOFI-AVENTIS
CONDITION
CANCER
DIABETES
ASTHMA
INFLUENZA
GEOGRAPHY
FRANCE
JAPAN
BELGIUM
GERMANY
DRUG
EMA
RIMONABANT
ROFECOXIB
216